🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareFDA compounding enforcement update — June 2026 guidance document Page 12

FDA compounding enforcement update — June 2026 guidance document

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 336 replies 53,782 viewsPage 12 of 20
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Mar 15, 2024 at 7:03 PM#56
VendorMark said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

37 12Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 34 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Mar 16, 2024 at 4:27 AM#57

Old thread, but it comes up first when you search for this, so it is worth updating. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

36 11BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 33 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Mar 16, 2024 at 1:51 PM#58

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

35 10paul_denver, TinaHashiRN, robert_kc and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Mar 16, 2024 at 11:15 PM#59
SarahChen_PharmD said:
The mechanism and the magnitude are separate questions.

Mine went the same way, slower. Nothing to add that would improve it.

34 9Admin, Dr.Martinez, mike_mod and 31 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Mar 17, 2024 at 8:40 AM#60
SarahChen_PharmD said:
The mechanism and the magnitude are separate questions.

Coming at SarahChen_PharmD’s question from a different direction. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

12 12A1cHero_PHX, Dr.RenalNash, LipidDoc_ATL and 9 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register